Efficacy and safety of interferon beta-1a for intramuscular injections biosimilar in patients with relapsing remitting multiple sclerosis
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the Neurological Sciences"
DOI: 10.1016/j.jns.2017.08.3473
Abstract: periependymal or diencephalic region, the areas considered as hallmarks of anti-AQP4 antibody positive-NMOSD brain lesions. Only one out of the four cases had prior infection, and the patients tended to relapse without induction of maintenance… read more here.
Keywords: injections biosimilar; beta intramuscular; efficacy safety; interferon beta ... See more keywords